diabetes glp-1 vs sglt2 GLP1 Receptor Agonists SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Cardiorenal Protection: Potential of SGLT2

Description

Steven Dayan, MD, is a plastic surgeon in Chicago

Periyalwar, this side effect comes from the way GLP-1s affect the digestive tract

A comprehensive virome analysis revealed a reduce core virome in CD patients compared with healthy controls, increased numbers of temperate phage sequences in CD individuals, and changes in virome composition which reflected alterations in bacterial composition in IBD, but no changes in viral richness [39]

Conclusion: Embarking on a medical weight loss journey with GLP-1 therapies involves navigating various aspects, and constipation is one consideration that shouldn't be overlooked

GLP-1 medications are commonly available as an injectable and are typically injected into subcutaneous or fatty tissue under their skin in certain areas of the body such as the abdomen, thigh or buttocks